X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (173) 173
index medicus (165) 165
oncology (159) 159
humans (151) 151
21-gene recurrence score (150) 150
female (147) 147
chemotherapy (119) 119
breast neoplasms - genetics (105) 105
prognosis (96) 96
middle aged (85) 85
cancer (80) 80
breast neoplasms - drug therapy (74) 74
breast neoplasms - pathology (74) 74
women (71) 71
tamoxifen (70) 70
gene-expression (68) 68
adjuvant chemotherapy (61) 61
adult (61) 61
aged (61) 61
assay (59) 59
oncotype dx (57) 57
estrogen-receptor (49) 49
21-gene assay (47) 47
gene expression (47) 47
risk (45) 45
gene expression profiling (41) 41
care and treatment (38) 38
genetic aspects (37) 37
neoplasm staging (37) 37
distant recurrence (36) 36
genes (36) 36
surgery (35) 35
medicine & public health (34) 34
receptors, estrogen - metabolism (34) 34
analysis (33) 33
biomarkers, tumor - genetics (33) 33
chemotherapy, adjuvant (33) 33
neoplasm recurrence, local - genetics (33) 33
decision-making (32) 32
impact (32) 32
decision making (30) 30
endocrine therapy (30) 30
recurrence score (30) 30
research (30) 30
retrospective studies (30) 30
breast neoplasms - metabolism (29) 29
gene expression profiling - methods (29) 29
therapy (29) 29
breast neoplasms - diagnosis (28) 28
estrogen (28) 28
breast neoplasms - therapy (26) 26
adjuvant treatment (25) 25
cancer therapies (25) 25
rt-pcr assay (25) 25
lymphatic metastasis (24) 24
patients (24) 24
cost-effectiveness (23) 23
immunohistochemistry (23) 23
international expert consensus (23) 23
risk factors (23) 23
tumors (23) 23
clinical-practice (22) 22
diagnosis (22) 22
expression (22) 22
health aspects (22) 22
pam50 risk (22) 22
postmenopausal patients (22) 22
article (21) 21
cost-benefit analysis (21) 21
erbb-2 protein (21) 21
prediction (21) 21
predictive value of tests (21) 21
recurrence (21) 21
risk assessment (21) 21
late distant recurrence (20) 20
receptors, estrogen - genetics (19) 19
aged, 80 and over (18) 18
progesterone-receptor (18) 18
receptor, erbb-2 - metabolism (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
breast neoplasms - chemistry (17) 17
clinical trials (17) 17
medical research (17) 17
neoplasm grading (17) 17
treatment outcome (17) 17
gene expression regulation, neoplastic (16) 16
genomics (16) 16
receptors, progesterone - metabolism (16) 16
recommendations (16) 16
survival (16) 16
validation (16) 16
biomarkers, tumor - metabolism (15) 15
breast neoplasms - economics (15) 15
follow-up studies (15) 15
hematology, oncology and palliative medicine (15) 15
lymph nodes (15) 15
pathology (15) 15
progesterone (15) 15
receptor, erbb-2 - genetics (15) 15
receptors, estrogen - analysis (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BMC Cancer, ISSN 1471-2407, 05/2018, Volume 18, Issue 1, pp. 526 - 10
Journal Article
Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 1, pp. 131 - 137
BACKGROUND A 21‐gene expression assay (Oncotype DX recurrence score [RS]) that uses reverse transcriptase‐polymerase chain reaction is used clinically in... 
low risk | 21‐gene expression assay | recurrence score | age | distant metastasis | 21-gene expression assay | ASSAY | CANCER | CHEMOTHERAPY | WOMEN | IMPACT | DECISION-MAKING | ONCOLOGY | RECOMMENDATIONS | GENE-EXPRESSION | END-POINTS | ASSOCIATION | Lymph Nodes - pathology | Prognosis | Follow-Up Studies | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Receptors, Progesterone - genetics | Neoplasm Recurrence, Local - pathology | Young Adult | Neoplasm Metastasis - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Adult | Female | Receptors, Estrogen - genetics | Gene Expression Profiling - methods | Breast Neoplasms - drug therapy | Neoplasm Metastasis - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Neoplasm Metastasis - pathology | Tamoxifen - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Care and treatment | Diagnosis | Research | Breast diseases | Gene expression | Lymphatic system | RNA-directed DNA polymerase | Identification methods | Estrogens | Estrogen receptors | Data processing | Breast cancer | Metastasis | Tamoxifen | Cancer therapies | Patients | ErbB-2 protein | Lymph nodes | Metastases | Polymerase chain reaction | Breast carcinoma | Chemotherapy | Epidermal growth factor | Cancer | Lymph
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 04/2020, Volume 20, Issue 2, pp. 125 - 130
Oncotype DX (ODX) is a genomic assay of tumor tissue that is utilized to predict the likelihood of recurrence and benefit of chemotherapy in breast cancer... 
Hereditary breast cancer | BRCA1 | BRCA2 | Genetic risk assessment | 21-Gene recurrence score assay | ASSAY | MUTATION CARRIERS | TAMOXIFEN | RISK | ESTROGEN-RECEPTOR | BREAST-CANCER | ONCOLOGY | EXPRESSION
Journal Article
The American Journal of Surgery, ISSN 0002-9610, 10/2018, Volume 216, Issue 4, pp. 689 - 693
American Society for Radiation Oncology (ASTRO) suitability criteria for accelerated partial breast irradiation (APBI) and the 21-gene recurrence score (RS)... 
Intraoperative radiation therapy | ASTRO suitability criteria for APBI | Breast cancer | 21-Gene recurrence score | Recurrences | SURGERY | ASSAY | TAMOXIFEN | OLDER | TRIAL | IRRADIATION | ONCOLOGY | RADIOTHERAPY | CONSENSUS STATEMENT | Carcinoma, Ductal, Breast - genetics | Breast Neoplasms - surgery | Prognosis | Follow-Up Studies | Humans | Middle Aged | Neoplasm Recurrence, Local - mortality | Carcinoma, Ductal, Breast - mortality | Aged, 80 and over | Adult | Female | Retrospective Studies | Radiotherapy, Adjuvant | Mastectomy, Segmental - methods | Carcinoma, Ductal, Breast - surgery | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Brachytherapy - methods | Decision Support Techniques | Neoplasm Recurrence, Local - diagnosis | Clinical Decision-Making - methods | Breast Neoplasms - radiotherapy | Breast Neoplasms - genetics | Intraoperative Care - methods | Carcinoma, Ductal, Breast - radiotherapy | Survival Analysis | Breast Neoplasms - mortality | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Care and treatment | Anopheles | Radioisotope brachytherapy | Genes | Radiation | Genetic research | Genetic aspects | Research institutes | Health aspects | Histochemistry | Cancer | Task forces | Demography | Estrogens | Clinical trials | Endocrine therapy | Data processing | Radiation therapy | Criteria | Cancer therapies | Patients | Noncompliance | Studies | Demographics | Chemotherapy | Histopathology | Mastectomy | Irradiation | Background radiation | Age | Tumors
Journal Article
Journal Article
Journal Article
Journal Article